Prospective Rheumatic Heart Disease & Healthy Control Serum Collection​

Boca Bio completed a targeted prospective serum collection for rheumatic heart disease research in approximately two months—nearly one month ahead of schedule. The study included a highly defined RHD cohort and age- and sex-matched healthy controls, supported by detailed demographic and clinical data, including vaccination status.